3M Company reported adjusted earnings of $2.14 per share for Q1 2026, exceeding analysts' estimates by 7.9%, while revenues hit $6.03 billion with a year-on-year growth of 3.9%. In light of persistent legal troubles, the company completed the spin-off of its healthcare division into Solventum, raising essential cash for these challenges. Although shares have seen significant volatility and are 11% down over the past five years, 3M's restructuring efforts and new product launches signal a commitment to innovation and operational stability for future growth.
“3M Company · adjusted earnings · $2.14 per share · surpassed the Zacks Consensus Estimate of $2.02”
“3M COMPANY · reported · first-quarter adjusted earnings · $2.14 per share”
“3M COMPANY · came in · revenue · in line with expectations”
“3M Co. · beat · on adjusted EPS · ($2.14)”
“Shares of 3M · have risen · over the past three years · nearly 70%”
“Shares of 3M · are still down · over the past five years · 11%”
“3M · has restructured · its business”
“3M · has legal issues · that continue to cast a dark cloud · over its future”
“3M · has a dividend yield · that is well above market · 2.1%”
“The Solventum spin-off · gives 3M · significant leeway · to address its legal troubles”
“3M · has been · a very volatile stock”
“3M · was spun off · its former healthcare division · to raise cash for legal issues”
